- Home
- YPF vs RVMD Comparison
YPF vs RVMD Comparison
Compare YPF & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | YPF | RVMD |
|---|---|---|
| Founded | 1977 | 2014 |
| Country | Argentina | United States |
| Employees | N/A | N/A |
| Industry | Integrated oil Companies | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.2B | 15.2B |
| IPO Year | 1993 | 2020 |
Fundamental Metrics
Financial Performance| Metric | YPF | RVMD |
|---|---|---|
| Price | $39.60 | $96.84 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 16 |
| Target Price | $41.67 | ★ $100.13 |
| AVG Volume (30 Days) | 1.5M | ★ 5.6M |
| Earning Date | 03-06-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $15,662,491,497.00 | N/A |
| Revenue This Year | $46.43 | N/A |
| Revenue Next Year | N/A | $740.40 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 41.18 | N/A |
| 52 Week Low | $22.82 | $29.17 |
| 52 Week High | $41.18 | $124.49 |
Technical Indicators
Market Signals| Indicator | YPF | RVMD |
|---|---|---|
| Relative Strength Index (RSI) | 70.83 | 46.96 |
| Support Level | $37.67 | $96.72 |
| Resistance Level | $35.42 | $101.93 |
| Average True Range (ATR) | 1.22 | 4.16 |
| MACD | 0.59 | -3.41 |
| Stochastic Oscillator | 91.20 | 15.13 |
Price Performance
Historical ComparisonAbout YPF YPF Sociedad Anonima
YPF SA is an Argentina-based integrated oil and gas company. It is engaged in operating a fully integrated oil and gas chain across the domestic upstream, downstream, and gas and power segments. Its upstream segment consists of exploration, development, and production of crude oil, natural gas, and LPG. Its downstream segment include refining, marketing, transportation, and distribution of oil and a wide range of petroleum products, petroleum derivatives, petrochemicals, LPG and bio-fuels. Gas and Power segment performs activities related to natural gas transportation to third parties and Downstream segment. Central Administration and Others includes activities performed by the Group not falling under the business segments. It generates maximum revenue from downstream segment.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.